Melody Noel Brown
Examiner (ID: 10713, Phone: (571)272-2599 , Office: P/2917 )
Most Active Art Unit | 2917 |
Art Unit(s) | 2911, 2901, 2915, 2917 |
Total Applications | 11779 |
Issued Applications | 11665 |
Pending Applications | 10 |
Abandoned Applications | 102 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 9409014
[patent_doc_number] => 20140100266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-10
[patent_title] => 'CANCER TREATMENT BY COMBINING DNA MOLECULES MIMICKING DOUBLE STRAND BREAKS WITH HYPERTHERMIA'
[patent_app_type] => utility
[patent_app_number] => 14/118583
[patent_app_country] => US
[patent_app_date] => 2012-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15685
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14118583
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/118583 | Cancer treatment by combining DNA molecules mimicking double strand breaks with hyperthermia | May 24, 2012 | Issued |
Array
(
[id] => 8503216
[patent_doc_number] => 20120302624
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-29
[patent_title] => 'BIOMARKER FOR IDENTIFYING SUBGROUP OF EARLY-STAGE LUNG ADENOCARCINOMA PATIENTS'
[patent_app_type] => utility
[patent_app_number] => 13/478835
[patent_app_country] => US
[patent_app_date] => 2012-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 13821
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13478835
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/478835 | Biomarker for identifying subgroup of early-stage lung adenocarcinoma patients | May 22, 2012 | Issued |
Array
(
[id] => 9086358
[patent_doc_number] => 08557787
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-15
[patent_title] => 'Diagnostic, prognostic and therapeutic uses of long non-coding RNAs for cancer and regenerative medicine'
[patent_app_type] => utility
[patent_app_number] => 13/470233
[patent_app_country] => US
[patent_app_date] => 2012-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 44
[patent_no_of_words] => 45058
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13470233
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/470233 | Diagnostic, prognostic and therapeutic uses of long non-coding RNAs for cancer and regenerative medicine | May 10, 2012 | Issued |
Array
(
[id] => 9858532
[patent_doc_number] => 20150038549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-05
[patent_title] => 'Methods and Compositions for Modulating Gene Expression Using Components That Self Assemble in Cells and Produce RNAi Activity'
[patent_app_type] => utility
[patent_app_number] => 14/113093
[patent_app_country] => US
[patent_app_date] => 2012-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 168
[patent_figures_cnt] => 168
[patent_no_of_words] => 43900
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113093
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/113093 | Methods and Compositions for Modulating Gene Expression Using Components That Self Assemble in Cells and Produce RNAi Activity | Apr 19, 2012 | Abandoned |
Array
(
[id] => 9512005
[patent_doc_number] => 20140148498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-29
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OF MARFAN SYNDROME AND ASSOCIATED DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/111176
[patent_app_country] => US
[patent_app_date] => 2012-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 21589
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14111176
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/111176 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MARFAN SYNDROME AND ASSOCIATED DISORDERS | Apr 12, 2012 | Abandoned |
Array
(
[id] => 8442030
[patent_doc_number] => 20120258646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-11
[patent_title] => 'Compositions for Controlling Varroa Mites in Bees'
[patent_app_type] => utility
[patent_app_number] => 13/446557
[patent_app_country] => US
[patent_app_date] => 2012-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15442
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13446557
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/446557 | Compositions for controlling Varroa mites in bees | Apr 12, 2012 | Issued |
Array
(
[id] => 13237427
[patent_doc_number] => 10131905
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-20
[patent_title] => Micro-RNA inhibitors and their uses in disease
[patent_app_type] => utility
[patent_app_number] => 14/111489
[patent_app_country] => US
[patent_app_date] => 2012-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 29
[patent_no_of_words] => 11657
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14111489
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/111489 | Micro-RNA inhibitors and their uses in disease | Apr 11, 2012 | Issued |
Array
(
[id] => 9318402
[patent_doc_number] => 20140050740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-20
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF TISSUE FIBROSIS'
[patent_app_type] => utility
[patent_app_number] => 14/111338
[patent_app_country] => US
[patent_app_date] => 2012-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 11638
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14111338
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/111338 | Compositions and methods for the treatment of tissue fibrosis | Apr 11, 2012 | Issued |
Array
(
[id] => 9375802
[patent_doc_number] => 08680066
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-25
[patent_title] => 'Methods for determining and inhibiting rheumatoid arthritis associated with the BRAF oncogene in a subject'
[patent_app_type] => utility
[patent_app_number] => 13/440942
[patent_app_country] => US
[patent_app_date] => 2012-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 7
[patent_no_of_words] => 15555
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13440942
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/440942 | Methods for determining and inhibiting rheumatoid arthritis associated with the BRAF oncogene in a subject | Apr 4, 2012 | Issued |
Array
(
[id] => 9281445
[patent_doc_number] => 20140031413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-30
[patent_title] => 'METHOD AND COMPOSITIONS COMPRISING SMALL RNA AGONIST AND ANTAGONISTS TO MODULATE INFLAMMATION'
[patent_app_type] => utility
[patent_app_number] => 14/007823
[patent_app_country] => US
[patent_app_date] => 2012-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 10748
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14007823
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/007823 | Method and compositions comprising small RNA agonist and antagonists to modulate inflammation | Apr 4, 2012 | Issued |
Array
(
[id] => 9181245
[patent_doc_number] => 20130323231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-05
[patent_title] => 'TREATMENT AND PROGNOSIS OF SOLID TUMOUR CANCERS'
[patent_app_type] => utility
[patent_app_number] => 13/985660
[patent_app_country] => US
[patent_app_date] => 2012-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6853
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13985660
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/985660 | TREATMENT AND PROGNOSIS OF SOLID TUMOUR CANCERS | Mar 29, 2012 | Abandoned |
Array
(
[id] => 10169621
[patent_doc_number] => 09200325
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-01
[patent_title] => 'Diagnostic methods and kit for detecting cancer'
[patent_app_type] => utility
[patent_app_number] => 13/433722
[patent_app_country] => US
[patent_app_date] => 2012-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 13
[patent_no_of_words] => 6571
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13433722
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/433722 | Diagnostic methods and kit for detecting cancer | Mar 28, 2012 | Issued |
Array
(
[id] => 9597809
[patent_doc_number] => 20140194489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-10
[patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF TMPRSS6 GENE'
[patent_app_type] => utility
[patent_app_number] => 14/007835
[patent_app_country] => US
[patent_app_date] => 2012-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 48556
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14007835
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/007835 | Compositions and methods for inhibiting expression of TMPRSS6 gene | Mar 27, 2012 | Issued |
Array
(
[id] => 8708649
[patent_doc_number] => 20130065938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'Mutator Activity Induced by microRNA-155 (miR-155) Links Inflammation and Cancer'
[patent_app_type] => utility
[patent_app_number] => 13/414084
[patent_app_country] => US
[patent_app_date] => 2012-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 11321
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13414084
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/414084 | Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer | Mar 6, 2012 | Issued |
Array
(
[id] => 9206076
[patent_doc_number] => 20140005253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING LUNG DISEASE AND INJURY'
[patent_app_type] => utility
[patent_app_number] => 14/002660
[patent_app_country] => US
[patent_app_date] => 2012-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 48793
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14002660
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/002660 | Compositions and methods for treating lung disease and injury | Feb 29, 2012 | Issued |
Array
(
[id] => 9307084
[patent_doc_number] => 20140045758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'Methods for Treating and Preventing Cardiac Dysfunction in Septic Shock'
[patent_app_type] => utility
[patent_app_number] => 14/000800
[patent_app_country] => US
[patent_app_date] => 2012-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 26240
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14000800
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/000800 | Methods for Treating and Preventing Cardiac Dysfunction in Septic Shock | Feb 20, 2012 | Abandoned |
Array
(
[id] => 9635520
[patent_doc_number] => 20140213629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-31
[patent_title] => 'MOLECULAR TARGETS FOR HEALING OR TREATING WOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/000532
[patent_app_country] => US
[patent_app_date] => 2012-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 5224
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14000532
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/000532 | MOLECULAR TARGETS FOR HEALING OR TREATING WOUNDS | Feb 16, 2012 | Abandoned |
Array
(
[id] => 9491883
[patent_doc_number] => 20140142288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'THERAPEUTIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/985023
[patent_app_country] => US
[patent_app_date] => 2012-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 35903
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13985023
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/985023 | Therapeutic compounds | Feb 12, 2012 | Issued |
Array
(
[id] => 9175241
[patent_doc_number] => 20130317226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'INHIBITORS OF THE INTERACTION OF THE SIGMA-1 RECEPTOR WITH hERG FOR USE IN THE TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/982775
[patent_app_country] => US
[patent_app_date] => 2012-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5802
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13982775
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/982775 | INHIBITORS OF THE INTERACTION OF THE SIGMA-1 RECEPTOR WITH hERG FOR USE IN THE TREATMENT OF CANCER | Jan 30, 2012 | Abandoned |
Array
(
[id] => 9108381
[patent_doc_number] => 20130281513
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'siRNA FOR INHIBITION OF Hif1alpha EXPRESSION AND ANTICANCER COMPOSITION CONTAINING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/993765
[patent_app_country] => US
[patent_app_date] => 2011-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12172
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13993765
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/993765 | siRNA FOR INHIBITION OF Hif1alpha EXPRESSION AND ANTICANCER COMPOSITION CONTAINING THE SAME | Dec 28, 2011 | Abandoned |